NEW YORK (GenomeWeb) – Trovagene said today it has closed a public offering of its common stock that brought in $23 million in gross proceeds. 

The company sold 5,111,110 shares of its shares, including 666,666 shares that were issued when the offering's underwriters exercised their overallotment option in full. The offering price was $4.50 per share, Trovagene said. The firm plans to use net proceeds for R&D, working capital, and other general corporate purposes. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.